French researchers pave the way for an allergy vaccine

This could make life easier for millions of French men and women, confronted with pollen allergies every year.. This year, the red alert has already been given in the Alpes-Maritimes and the Var.

Allergies are also at the forefront in the onset of chronic asthma. According to Inserm, allergic asthma accounts for approximately 50% of asthma cases.

This Toulouse vaccine targets overproduction of antibodies triggered by exposure to allergens, including dust mites, as this is what causes allergic reactions, specifies the Midi Libre website.

For Laurent Reber, research director at Inserm, “This study provides proof of concept for the efficacy of the vaccine in neutralizing human proteins that play a key role in allergic asthma”report our colleagues.

In animals that were vaccinated, significant effects on symptoms were observed. The results are promising since “Three months after the injection, the effectiveness does not weaken”. The way is opening more and more to the organization “clinical trials”.

As always stated Free lunchwhat a vaccine could be useful “not only for people with asthma”but also for pathologies such as atopic dermatitis (or eczema) and food allergies.